DPharm 2026
- Dates
- 15–16 September 2026
- Location
- Boston, Massachusetts, United States
- Venue
- Sheraton Boston
- Host
- The Conference Forum (published by Questex LLC)
- Edition
- 16th Annual
- Roster as of
- 7 September 2026
DPHARM, registered as "Disruptive Innovations to Advance Clinical Research", is presented by The Conference Forum as a conference on modernizing clinical research. It brings senior clinical operations executives and technologists together to present new approaches to clinical trial design and execution. The organizer states that the event connects 1,000+ industry executives, innovators and change-makers; that is the organizer's own figure, and no attendee data is held on this page.
Key statistics
Aggregate revenue is a sum of industryGENOME's per-company estimates for the 97 exhibitors with revenue above zero. Oracle and Thermo Fisher Scientific account for $102.0B — 66% — of it. It is not a market size; the median is the more representative figure. Primary node is the ICCS® branch carrying the most exhibitors, of 96 with node data; it does not describe what the conference is about.
Industry node stratification
Size stratification
Ownership
Exhibitors at DPharm 2026 with an industryGENOME record — 107 of 117. Companies per ownership type.
Ownership type as recorded by industryGENOME. Select a band to see which companies are in it.
Founding year
Exhibitors at DPharm 2026 with a founding year on file — 100 of 107; 7 have no founding year on file. Companies founded in each year, 1956 to 2024. Click a year to see which companies.
Exhibitor ICCS® leaf nodes
All 440 ICCS® leaf nodes carried by the 96 of 117 exhibitors with node data. Two populations appear on each strip and are measured differently: exhibitors at DPharm 2026, and companies industryGENOME tracks in the node (profiled, revenue-bearing, non-acquired). They are never joined. Allocated leaf-node revenue is the sum of industryGENOME's revenue allocation to that node across the exhibitors carrying it — a sum of estimates, not a market size; across all 440 nodes it partitions the floor without double-counting. Node names and exhibitor names link to their industryGENOME pages. The industryGENOME count is shown where extracted, which is the 68 nodes carried by ten or more exhibitors; the other 372 show a dash. Definitions are shown for the same 68.
Headquarters
Headquarters country and US state of the exhibitors at DPharm 2026 with an industryGENOME record — 107 of 117. Shading counts companies headquartered in each area: where a company is based, not where its revenue or staff are allocated. The allocation view, which distributes each company's estimated revenue and employees across countries and states for the 93 exhibitors with geographic data, is part of the full record.
United States
Exhibitors headquartered in the US — of 107, by state.
Hover a state for its count; click it to see which companies are headquartered there.
Europe
Exhibitors headquartered in Europe — of 107, by country.
Europe here is GB, CH, FR, DE, SE, IE, FI, NL and BE, as recorded. Hover a country for its count; click it to see which companies.
Global
Exhibitors with a recorded headquarters country — of 107, in countries; 3 have none recorded and are on no map.
The exhibitors
All 117 exhibitors on the published DPharm 2026 roster, as of 7 September 2026. 107 have an industryGENOME record and are shown with industryGENOME's name and one-line descriptor; 10 do not and are shown as the roster prints them. Employees, ownership, headquarters and primary branch are free and sortable; sorting by revenue requires sign-in. Primary branch is the top-level ICCS® branch carrying the largest share of the company's allocated revenue, with that share; 72 of 96 companies span more than one branch, and 12 have a primary branch below 50%.